Xavier Llor researcher (ORCID 0000-0002-6259-185X)
Llor, Xavier
Llor, Xavier, 19..-....
VIAF ID: 11161632308510642628 (Personal)
Permalink: http://viaf.org/viaf/11161632308510642628
Preferred Forms
- 100 1 _ ‡a Llor, Xavier
- 100 1 _ ‡a Llor, Xavier
- 100 1 _ ‡a Llor, Xavier, ‡d 19..-....
- 100 0 _ ‡a Xavier Llor ‡c researcher (ORCID 0000-0002-6259-185X)
4xx's: Alternate Name Forms (1)
Works
Title | Sources |
---|---|
AGA White Paper: Roadmap for the Future of Colorectal Cancer Screening in the United States | |
Association of MUTYH and MSH6 germline mutations in colorectal cancer patients. | |
Cancer genetics, 2021: | |
Clinical features and cancer risk in families with pathogenic CDH1 variants irrespective of clinical criteria | |
Colorectal cancers with microsatellite instability display unique miRNA profiles. | |
Comparison between universal molecular screening for Lynch syndrome and revised Bethesda guidelines in a large population-based cohort of patients with colorectal cancer | |
Evidence for classification of c.1852_1853AA>GC in MLH1 as a neutral variant for Lynch syndrome | |
Methylation analysis of MLH1 improves the selection of patients for genetic testing in Lynch syndrome. | |
Multiple sporadic colorectal cancers display a unique methylation phenotype | |
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 3.2017. | |
Phenotypic differences in Juvenile Polyposis Syndrome with or without a disease-causing SMAD4/BMPR1A variant | |
Prevalence of MLH1 constitutional epimutations as a cause of Lynch syndrome in unselected versus selected consecutive series of patients with colorectal cancer. | |
Prevalence of somatic mutl homolog 1 promoter hypermethylation in Lynch syndrome colorectal cancer | |
Risk of cancer in cases of suspected lynch syndrome without germline mutation. |